Dominant-negative effect of truncated mannose 6-phosphate/insulin-like growth factor II receptor species in cancer

Soluble M6P/IGF2R Released by TACE Controls Angiogenesis via Blocking Plasminogen Activation

(2011) Vladimir Leksa et al.   CIRCULATION RESEARCH

Glycosylation-independent binding to extracellular domains 11–13 of mannose-6-phosphate/insulin-like growth factor-2 receptor mediates the effects of soluble CREG on the phenotypic modulation of vascular smooth muscle cells

(2010) Yaling Han et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis

(2009) Irena Martin-Kleiner et al.   CANCER LETTERS

Role of ADAMs in Cancer Formation and Progression

(2009) M. J. Duffy et al.   CLINICAL CANCER RESEARCH

CREG inhibits migration of human vascular smooth muscle cells by mediating IGF-II endocytosis

(2009) Yaling Han et al.   EXPERIMENTAL CELL RESEARCH

High-affinity ligand binding by wild-type/mutant heteromeric complexes of the mannose 
6-phosphate/insulin-like growth factor II receptor

(2009) Michelle A. Hartman et al.   FEBS Journal

Keeping IGF-II under control: Lessons from the IGF-II–IGF2R crystal structure

(2009) James Brown et al.   TRENDS IN BIOCHEMICAL SCIENCES

Cellular repressor of E1A-stimulated genes is a bona fide lysosomal protein which undergoes proteolytic maturation during its biosynthesis

(2008) Philipp Schähs et al.   EXPERIMENTAL CELL RESEARCH

Secreted CREG inhibits cell proliferation mediated by mannose 6-phosphate/insulin-like growth factor II receptor in NIH3T3 fibroblasts

(2008) Ya-Ling Han et al.   GENES TO CELLS

The ADAM metalloproteinases

(2008) D EDWARDS et al.   MOLECULAR ASPECTS OF MEDICINE